Optic Nerve Disorders Treatment Market, Global Outlook and Forecast 2022-2028

April 2022 | 68 pages | ID: OB8D9B77902AEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Optic Nerve Disorders Treatment in Global, including the following market information:

Global Optic Nerve Disorders Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Optic Nerve Disorders Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Medical Treatment Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Optic Nerve Disorders Treatment include Santen Pharmaceutical Co., Ltd., Allergan plc (AbbVie Inc.), Novartis AG, Pfizer, Inc., Bausch Health Companies, Inc., Aerie Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., Bionure Farma, S.L. and Mallinckrodt Pharmaceuticals. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Optic Nerve Disorders Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Optic Nerve Disorders Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Optic Nerve Disorders Treatment Market Segment Percentages, by Type, 2021 (%)

• Medical Treatment
• Surgical Treatment

Global Optic Nerve Disorders Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Optic Nerve Disorders Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinic
• Others

Global Optic Nerve Disorders Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Optic Nerve Disorders Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Optic Nerve Disorders Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Optic Nerve Disorders Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Santen Pharmaceutical Co., Ltd.
• Allergan plc (AbbVie Inc.)
• Novartis AG
• Pfizer, Inc.
• Bausch Health Companies, Inc.
• Aerie Pharmaceuticals, Inc.
• Teva Pharmaceutical Industries Ltd.
• Bionure Farma, S.L.
• Mallinckrodt Pharmaceuticals

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Optic Nerve Disorders Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Optic Nerve Disorders Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL OPTIC NERVE DISORDERS TREATMENT OVERALL MARKET SIZE

2.1 Global Optic Nerve Disorders Treatment Market Size: 2021 VS 2028
2.2 Global Optic Nerve Disorders Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Optic Nerve Disorders Treatment Players in Global Market
3.2 Top Global Optic Nerve Disorders Treatment Companies Ranked by Revenue
3.3 Global Optic Nerve Disorders Treatment Revenue by Companies
3.4 Top 3 and Top 5 Optic Nerve Disorders Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Optic Nerve Disorders Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Optic Nerve Disorders Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Optic Nerve Disorders Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Optic Nerve Disorders Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Optic Nerve Disorders Treatment Market Size Markets, 2021 & 2028
  4.1.2 Medical Treatment
  4.1.3 Surgical Treatment
4.2 By Type - Global Optic Nerve Disorders Treatment Revenue & Forecasts
  4.2.1 By Type - Global Optic Nerve Disorders Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Optic Nerve Disorders Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Optic Nerve Disorders Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Optic Nerve Disorders Treatment Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Clinic
  5.1.4 Others
5.2 By Application - Global Optic Nerve Disorders Treatment Revenue & Forecasts
  5.2.1 By Application - Global Optic Nerve Disorders Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Optic Nerve Disorders Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Optic Nerve Disorders Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Optic Nerve Disorders Treatment Market Size, 2021 & 2028
6.2 By Region - Global Optic Nerve Disorders Treatment Revenue & Forecasts
  6.2.1 By Region - Global Optic Nerve Disorders Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Optic Nerve Disorders Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Optic Nerve Disorders Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Optic Nerve Disorders Treatment Revenue, 2017-2028
  6.3.2 US Optic Nerve Disorders Treatment Market Size, 2017-2028
  6.3.3 Canada Optic Nerve Disorders Treatment Market Size, 2017-2028
  6.3.4 Mexico Optic Nerve Disorders Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Optic Nerve Disorders Treatment Revenue, 2017-2028
  6.4.2 Germany Optic Nerve Disorders Treatment Market Size, 2017-2028
  6.4.3 France Optic Nerve Disorders Treatment Market Size, 2017-2028
  6.4.4 U.K. Optic Nerve Disorders Treatment Market Size, 2017-2028
  6.4.5 Italy Optic Nerve Disorders Treatment Market Size, 2017-2028
  6.4.6 Russia Optic Nerve Disorders Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Optic Nerve Disorders Treatment Market Size, 2017-2028
  6.4.8 Benelux Optic Nerve Disorders Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Optic Nerve Disorders Treatment Revenue, 2017-2028
  6.5.2 China Optic Nerve Disorders Treatment Market Size, 2017-2028
  6.5.3 Japan Optic Nerve Disorders Treatment Market Size, 2017-2028
  6.5.4 South Korea Optic Nerve Disorders Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Optic Nerve Disorders Treatment Market Size, 2017-2028
  6.5.6 India Optic Nerve Disorders Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Optic Nerve Disorders Treatment Revenue, 2017-2028
  6.6.2 Brazil Optic Nerve Disorders Treatment Market Size, 2017-2028
  6.6.3 Argentina Optic Nerve Disorders Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Optic Nerve Disorders Treatment Revenue, 2017-2028
  6.7.2 Turkey Optic Nerve Disorders Treatment Market Size, 2017-2028
  6.7.3 Israel Optic Nerve Disorders Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Optic Nerve Disorders Treatment Market Size, 2017-2028
  6.7.5 UAE Optic Nerve Disorders Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Santen Pharmaceutical Co., Ltd.
  7.1.1 Santen Pharmaceutical Co., Ltd. Corporate Summary
  7.1.2 Santen Pharmaceutical Co., Ltd. Business Overview
  7.1.3 Santen Pharmaceutical Co., Ltd. Optic Nerve Disorders Treatment Major Product Offerings
  7.1.4 Santen Pharmaceutical Co., Ltd. Optic Nerve Disorders Treatment Revenue in Global Market (2017-2022)
  7.1.5 Santen Pharmaceutical Co., Ltd. Key News
7.2 Allergan plc (AbbVie Inc.)
  7.2.1 Allergan plc (AbbVie Inc.) Corporate Summary
  7.2.2 Allergan plc (AbbVie Inc.) Business Overview
  7.2.3 Allergan plc (AbbVie Inc.) Optic Nerve Disorders Treatment Major Product Offerings
  7.2.4 Allergan plc (AbbVie Inc.) Optic Nerve Disorders Treatment Revenue in Global Market (2017-2022)
  7.2.5 Allergan plc (AbbVie Inc.) Key News
7.3 Novartis AG
  7.3.1 Novartis AG Corporate Summary
  7.3.2 Novartis AG Business Overview
  7.3.3 Novartis AG Optic Nerve Disorders Treatment Major Product Offerings
  7.3.4 Novartis AG Optic Nerve Disorders Treatment Revenue in Global Market (2017-2022)
  7.3.5 Novartis AG Key News
7.4 Pfizer, Inc.
  7.4.1 Pfizer, Inc. Corporate Summary
  7.4.2 Pfizer, Inc. Business Overview
  7.4.3 Pfizer, Inc. Optic Nerve Disorders Treatment Major Product Offerings
  7.4.4 Pfizer, Inc. Optic Nerve Disorders Treatment Revenue in Global Market (2017-2022)
  7.4.5 Pfizer, Inc. Key News
7.5 Bausch Health Companies, Inc.
  7.5.1 Bausch Health Companies, Inc. Corporate Summary
  7.5.2 Bausch Health Companies, Inc. Business Overview
  7.5.3 Bausch Health Companies, Inc. Optic Nerve Disorders Treatment Major Product Offerings
  7.5.4 Bausch Health Companies, Inc. Optic Nerve Disorders Treatment Revenue in Global Market (2017-2022)
  7.5.5 Bausch Health Companies, Inc. Key News
7.6 Aerie Pharmaceuticals, Inc.
  7.6.1 Aerie Pharmaceuticals, Inc. Corporate Summary
  7.6.2 Aerie Pharmaceuticals, Inc. Business Overview
  7.6.3 Aerie Pharmaceuticals, Inc. Optic Nerve Disorders Treatment Major Product Offerings
  7.6.4 Aerie Pharmaceuticals, Inc. Optic Nerve Disorders Treatment Revenue in Global Market (2017-2022)
  7.6.5 Aerie Pharmaceuticals, Inc. Key News
7.7 Teva Pharmaceutical Industries Ltd.
  7.7.1 Teva Pharmaceutical Industries Ltd. Corporate Summary
  7.7.2 Teva Pharmaceutical Industries Ltd. Business Overview
  7.7.3 Teva Pharmaceutical Industries Ltd. Optic Nerve Disorders Treatment Major Product Offerings
  7.7.4 Teva Pharmaceutical Industries Ltd. Optic Nerve Disorders Treatment Revenue in Global Market (2017-2022)
  7.7.5 Teva Pharmaceutical Industries Ltd. Key News
7.8 Bionure Farma, S.L.
  7.8.1 Bionure Farma, S.L. Corporate Summary
  7.8.2 Bionure Farma, S.L. Business Overview
  7.8.3 Bionure Farma, S.L. Optic Nerve Disorders Treatment Major Product Offerings
  7.8.4 Bionure Farma, S.L. Optic Nerve Disorders Treatment Revenue in Global Market (2017-2022)
  7.8.5 Bionure Farma, S.L. Key News
7.9 Mallinckrodt Pharmaceuticals
  7.9.1 Mallinckrodt Pharmaceuticals Corporate Summary
  7.9.2 Mallinckrodt Pharmaceuticals Business Overview
  7.9.3 Mallinckrodt Pharmaceuticals Optic Nerve Disorders Treatment Major Product Offerings
  7.9.4 Mallinckrodt Pharmaceuticals Optic Nerve Disorders Treatment Revenue in Global Market (2017-2022)
  7.9.5 Mallinckrodt Pharmaceuticals Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Optic Nerve Disorders Treatment Market Opportunities & Trends in Global Market
Table 2. Optic Nerve Disorders Treatment Market Drivers in Global Market
Table 3. Optic Nerve Disorders Treatment Market Restraints in Global Market
Table 4. Key Players of Optic Nerve Disorders Treatment in Global Market
Table 5. Top Optic Nerve Disorders Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Optic Nerve Disorders Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Optic Nerve Disorders Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Optic Nerve Disorders Treatment Product Type
Table 9. List of Global Tier 1 Optic Nerve Disorders Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Optic Nerve Disorders Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Optic Nerve Disorders Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Optic Nerve Disorders Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Optic Nerve Disorders Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Optic Nerve Disorders Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Optic Nerve Disorders Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Optic Nerve Disorders Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Optic Nerve Disorders Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Optic Nerve Disorders Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Optic Nerve Disorders Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Optic Nerve Disorders Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Optic Nerve Disorders Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Optic Nerve Disorders Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Optic Nerve Disorders Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Optic Nerve Disorders Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Optic Nerve Disorders Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Optic Nerve Disorders Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Optic Nerve Disorders Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Optic Nerve Disorders Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Optic Nerve Disorders Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Santen Pharmaceutical Co., Ltd. Corporate Summary
Table 31. Santen Pharmaceutical Co., Ltd. Optic Nerve Disorders Treatment Product Offerings
Table 32. Santen Pharmaceutical Co., Ltd. Optic Nerve Disorders Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Allergan plc (AbbVie Inc.) Corporate Summary
Table 34. Allergan plc (AbbVie Inc.) Optic Nerve Disorders Treatment Product Offerings
Table 35. Allergan plc (AbbVie Inc.) Optic Nerve Disorders Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Novartis AG Corporate Summary
Table 37. Novartis AG Optic Nerve Disorders Treatment Product Offerings
Table 38. Novartis AG Optic Nerve Disorders Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Pfizer, Inc. Corporate Summary
Table 40. Pfizer, Inc. Optic Nerve Disorders Treatment Product Offerings
Table 41. Pfizer, Inc. Optic Nerve Disorders Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Bausch Health Companies, Inc. Corporate Summary
Table 43. Bausch Health Companies, Inc. Optic Nerve Disorders Treatment Product Offerings
Table 44. Bausch Health Companies, Inc. Optic Nerve Disorders Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Aerie Pharmaceuticals, Inc. Corporate Summary
Table 46. Aerie Pharmaceuticals, Inc. Optic Nerve Disorders Treatment Product Offerings
Table 47. Aerie Pharmaceuticals, Inc. Optic Nerve Disorders Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Teva Pharmaceutical Industries Ltd. Corporate Summary
Table 49. Teva Pharmaceutical Industries Ltd. Optic Nerve Disorders Treatment Product Offerings
Table 50. Teva Pharmaceutical Industries Ltd. Optic Nerve Disorders Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Bionure Farma, S.L. Corporate Summary
Table 52. Bionure Farma, S.L. Optic Nerve Disorders Treatment Product Offerings
Table 53. Bionure Farma, S.L. Optic Nerve Disorders Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Mallinckrodt Pharmaceuticals Corporate Summary
Table 55. Mallinckrodt Pharmaceuticals Optic Nerve Disorders Treatment Product Offerings
Table 56. Mallinckrodt Pharmaceuticals Optic Nerve Disorders Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Optic Nerve Disorders Treatment Segment by Type in 2021
Figure 2. Optic Nerve Disorders Treatment Segment by Application in 2021
Figure 3. Global Optic Nerve Disorders Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Optic Nerve Disorders Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Optic Nerve Disorders Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Optic Nerve Disorders Treatment Revenue in 2021
Figure 8. By Type - Global Optic Nerve Disorders Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Optic Nerve Disorders Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Optic Nerve Disorders Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Optic Nerve Disorders Treatment Revenue Market Share, 2017-2028
Figure 12. US Optic Nerve Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Optic Nerve Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Optic Nerve Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Optic Nerve Disorders Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Optic Nerve Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Optic Nerve Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Optic Nerve Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Optic Nerve Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Optic Nerve Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Optic Nerve Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Optic Nerve Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Optic Nerve Disorders Treatment Revenue Market Share, 2017-2028
Figure 24. China Optic Nerve Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Optic Nerve Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Optic Nerve Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Optic Nerve Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Optic Nerve Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Optic Nerve Disorders Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Optic Nerve Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Optic Nerve Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Optic Nerve Disorders Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Optic Nerve Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Optic Nerve Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Optic Nerve Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Optic Nerve Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Santen Pharmaceutical Co., Ltd. Optic Nerve Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Allergan plc (AbbVie Inc.) Optic Nerve Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Novartis AG Optic Nerve Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Pfizer, Inc. Optic Nerve Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Bausch Health Companies, Inc. Optic Nerve Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Aerie Pharmaceuticals, Inc. Optic Nerve Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Teva Pharmaceutical Industries Ltd. Optic Nerve Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Bionure Farma, S.L. Optic Nerve Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Mallinckrodt Pharmaceuticals Optic Nerve Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)